US 12281079
Quinoline derivatives, processes for their preparation and uses thereof for the treatment of cancer
granted A61KA61K31/4375A61K31/438
Quick answer
US patent 12281079 (Quinoline derivatives, processes for their preparation and uses thereof for the treatment of cancer) held by Lead Discovery Center GmbH expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Lead Discovery Center GmbH
- Grant date
- Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/4375, A61K31/438, A61K31/47, A61K31/4709